¼¼°èÀÇ °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå : Á¦Ç° À¯Çü, ¿ëµµ, Æ÷À庰 ¿¹Ãø(2025-2030³â)
Canine Oral Chewable Tablets Market by Product Type (Non-Prescription Tablets, Prescription Tablets), Application (Dental Treatment, Oral Health Maintenance), Packaging - Global Forecast 2025-2030
»óǰÄÚµå : 1573118
¸®¼­Ä¡»ç : 360iResearch Private Limited
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 189 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,939 £Ü 5,699,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 4,249 £Ü 6,147,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 5,759 £Ü 8,332,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ Áö¿ª »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 6,969 £Ü 10,083,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀº 2023³â¿¡ 31 ¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 33¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.42%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 45 ¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀº ÁÖ·Î ¹Ý·Áµ¿¹° °Ç°­ °ü¸®, ƯÈ÷ °³ ±¸°­ À§»ý, Ç× ±â»ýÃæ Ä¡·á ¹× ¿µ¾ç º¸Á¶ ½ÄǰÀ» Áß½ÉÀ¸·Î Àü°³µË´Ï´Ù. ÀÌ Á¦Ç°Àº ¼ÒÈ­±â°è¿Í ±¸°­ °Ç°­À» °³¼±ÇÏ°í º­·è°ú Áøµå±â¸¦ Á¦°ÅÇϰí Çʼö ¿µ¾ç¼Ò¸¦ °ø±ÞÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¤Á¦ÀÇ Çʿ伺Àº ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ ÀǽÄ, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ ÀÇ¿å Áõ°¡·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§¿¡´Â ÁÖ·Î µ¿¹° º´¿ø, ¹Ý·Áµ¿¹° °¡°Ô, ¿Â¶óÀÎ ¼Ò¸Å ä³ÎÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­ µ¿Çâ¿¡ Å©°Ô ¿µÇâÀ»¹ÞÀ¸¸ç ÇÁ¸®¹Ì¾ö ¹Ý·Áµ¿¹° °Ç°­ Á¦Ç° ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°¿ë ÀǾàǰ »ê¾÷¿¡¼­ R&D Áõ°¡¿Í ¿Â¶óÀÎ ¼Ò¸ÅÀÇ ±ÞÁõÀº ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ ½Ã»çÇÕ´Ï´Ù. ±â¾÷Àº ¼ÒÈ­±â°èÀÇ °Ç°­À» À§ÇÑ ÇÁ·Î¹ÙÀÌ¿Àƽ½º³ª, ³ëÀΰßÀÇ ¿¹¹æ ´ëÃ¥À¸·Î¼­ÀÇ °üÀý Äɾî Á¦Ç° µî, ƯÁ¤ÀÇ °Ç°­ ¹®Á¦¿¡ ´ëÀÀÇÏ´Â Á¦Ç° ¶óÀÎÀÇ È®´ë¸¦ °ËÅäÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦¿Í °³¹ßµµ»óÁö¿ªÀÇ ÀνĺÎÁ·ÀÌ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ ÁÖÀÎÀº °¡°Ý¿¡ ¹Î°¨Çϰí ÀÏ¹Ý Á¦¾à°úÀÇ °æÀïÀº ½ÃÀåÀÇ ±Þ¼ºÀåÀ» ´õ¿í ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¾÷°èÀÇ Çõ½ÅÀº Á¦Ç°ÀÇ ¼±È£µµ, ¿µ¾ç°¡ Çâ»ó, ģȯ°æ ÆÐŰ¡ ¼Ö·ç¼Ç¿¡ ÁßÁ¡À» µÑ ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼®À» ÀÌ¿ëÇÑ °³ÀÎÈ­µÈ °Ç°­ °ü¸® °³¹ßÀº °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå »óȲÀº ²ÙÁØÇÑ ¼ºÀåÀ» º¸À̰í ÀÖÁö¸¸ ½ÃÀåÀÇ ¼º°ÝÀº ¿©ÀüÈ÷ °æÀïÀûÀÌ°í ´ÜÆíÀûÀÌ¸ç ´ë±â¾÷Àº ¸¶ÄÉÆÃ Àü·«°ú Á¦Ç° Â÷º°È­ Àü·«¿¡ ´ë±Ô¸ð ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ÇѰ踦 ´Ù·ç±â À§Çؼ­´Â À¯Åë¸ÁÀ» °­È­ÇÏ°í °æ±¸ Ãò¾îºí Ÿºí·¿ÀÇ ÀåÁ¡À» ¼ÒºñÀÚ¿¡°Ô °è¸ùÇÔÀ¸·Î½á ½ÃÀå ÁøÀÔ°ú ¼ö¿ëÀ» È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁøÈ­ÇÏ´Â ¼ÒºñÀÚÀÇ ÃëÇâÀº ±â¾÷ÀÌ Áö¼ÓÀûÀ¸·Î Çõ½ÅÀ» Çϰí, Á¤±³ÇÑ Á¤º¸ÅëÀÇ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚÃþ¿¡ ´ëÀÀÇÏ´Â ¿øµ¿·ÂÀÌ µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 31¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 33¾ï ´Þ·¯
¿¹Ãø³â(2030) 45¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 5.42%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Porter's Five Forces: °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Force Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

°³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸³´Ï´Ù.

°³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦7Àå °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå : ¿ëµµº°

Á¦8Àå °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå : ÆÐŰ¡º°

Á¦9Àå ¾Æ¸Þ¸®Ä« °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °³¿ë °æ±¸ Ãò¾îºí Ÿºí·¿ ½ÃÀå

Á¦12Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Canine Oral Chewable Tablets Market was valued at USD 3.16 billion in 2023, expected to reach USD 3.30 billion in 2024, and is projected to grow at a CAGR of 5.42%, to USD 4.58 billion by 2030.

The market for Canine Oral Chewable Tablets predominantly revolves around pet healthcare, especially considering oral hygiene, anti-parasitic treatments, and dietary supplements for dogs. These products cater to improving digestive and oral health, controlling fleas and ticks, and delivering essential nutrients. The necessity for these tablets arises from increasing pet ownership, awareness regarding pet health, and a rising willingness among pet owners to invest in preventive healthcare. The end-use scope primarily encompasses veterinary clinics, pet stores, and online retail channels. Growth in this market is significantly influenced by the trend of humanization of pets, which drives demand for premium pet healthcare products. Increased R&D in the pet pharmaceutical industry, along with an upsurge in online retailing, signifies potential opportunities. Companies can consider expanding product lines to address specific health issues, such as probiotics for digestive health or joint care products as preventive measures for aging dogs. However, stringent regulations, coupled with a lack of awareness in developing regions, pose challenges. Price sensitivity among pet owners and competition from generic counterpart offerings further inhibit rapid market growth. Innovations in this industry could focus on enhancing product palatability and nutritional value, as well as eco-friendly packaging solutions. The development of personalized healthcare regimens using data analytics could offer competitive advantages. While the market landscape exhibits steady growth, the nature of the market remains competitive and fragmented, with major players investing extensively in marketing and product differentiation strategies. To address market limitations, strengthening distribution networks and educating consumers on the benefits of oral chewable tablets can widen reach and acceptance. The evolving consumer preferences provide an impetus for companies to innovate continuously and cater to a sophisticated and informed pet owner demographic.

KEY MARKET STATISTICS
Base Year [2023] USD 3.16 billion
Estimated Year [2024] USD 3.30 billion
Forecast Year [2030] USD 4.58 billion
CAGR (%) 5.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Oral Chewable Tablets Market

The Canine Oral Chewable Tablets Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Porter's Five Forces: A Strategic Tool for Navigating the Canine Oral Chewable Tablets Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Oral Chewable Tablets Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Oral Chewable Tablets Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Oral Chewable Tablets Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Oral Chewable Tablets Market

A detailed market share analysis in the Canine Oral Chewable Tablets Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Oral Chewable Tablets Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Oral Chewable Tablets Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Oral Chewable Tablets Market

A strategic analysis of the Canine Oral Chewable Tablets Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Oral Chewable Tablets Market, highlighting leading vendors and their innovative profiles. These include Bayer Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Colgate-Palmolive Company, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Hill's Pet Nutrition, Inc., Mars Petcare, Merck Animal Health, Nestle Purina PetCare, Nutramax Laboratories Veterinary Sciences, Inc., Phibro Animal Health Corporation, Royal Canin, Vetoquinol S.A., Virbac S.A., WellPet LLC, Zoetis Inc., and Zooplus AG.

Market Segmentation & Coverage

This research report categorizes the Canine Oral Chewable Tablets Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Canine Oral Chewable Tablets Market, by Product Type

7. Canine Oral Chewable Tablets Market, by Application

8. Canine Oral Chewable Tablets Market, by Packaging

9. Americas Canine Oral Chewable Tablets Market

10. Asia-Pacific Canine Oral Chewable Tablets Market

11. Europe, Middle East & Africa Canine Oral Chewable Tablets Market

12. Competitive Landscape

Companies Mentioned

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â